CSF3, colony stimulating factor 3, 1440

N. diseases: 687; N. variants: 4
Disease: B-Cell Lymphomas ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0079731
Disease: B-Cell Lymphomas
B-Cell Lymphomas 		0.320 Biomarker group BEFREE We suggest routine use of peg-GCSF is an acceptable alternative to daily GCSF, for patients in whom da-EPOCH-R is selected as first-line treatment for aggressive B-NHL. 28870643 2017
CUI: C0079731
Disease: B-Cell Lymphomas
B-Cell Lymphomas 		0.320 Biomarker group BEFREE Peripheral blood stem cell mobilization following CHOP plus rituximab therapy combined with G-CSF in patients with B-cell non-Hodgkin's lymphoma. 14743197 2004
CUI: C0079731
Disease: B-Cell Lymphomas
B-Cell Lymphomas 		0.320 Therapeutic group CTD_human A comparative study of sequential priming and mobilisation of progenitor cells with rhG-CSF alone and high-dose cyclophosphamide plus rhG-CSF. 11042651 2000